Pfizer Launches First-Ever COVID-19 Pill, Prevents Virus Mutation Inside the Human Cells
Kort samengevat
Pfizer Inc has started early-stage human trials of a new oral drug that could be administered to patients as soon as they show symptoms of COVID-19 infection.
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij HNGN - Headlines & Global News.
Lees het volledige bericht ↗